Providing CoA/CoT, HPLC and MS data, barcode-mapped plate layouts, and optional raw-data packages for full traceability and quality assurance.
- Listeelement #1
- Listeelement #2
- Listeelement #3
Short and long peptides synthesized from patient‑specific mutations with rapid turnaround, scalable purification and analytical release, supplied as single or pooled sets.
Peptides available at >90%, >95%, or >98% purity levels, tailored to research or clinical program requirements.
Offering pooled peptide sets, equimolar mixing, and 96-well plate layouts with complete sequence mapping.
Providing GMP alignment, QA documentation, and full audit support to meet regulatory and client expectations.
8–11mers for MHC‑I, 12–30+ aa long peptides for MHC‑II or vaccines.
Defined pools or 96‑well plate format with barcodes and traceability.
N/C‑termini, linker tags, conjugation (e.g., KLH/biotin) by request.
HPLC/UPLC purity and MS identity; CoA/CoT and data packages.
Lyophilized aliquots, salt/counter‑ion control, controlled shipping.
From single neoepitopes to 20–200+ peptide sets per patient.
Providing CoA/CoT, HPLC and MS data, barcode-mapped plate layouts, and optional raw-data packages for full traceability and quality assurance.
Certificate of Analysis or Test provided per peptide or per pool for complete transparency.
Barcode-labeled layouts with clear identifiers ensuring accurate tracking and organization.
Delivering detailed HPLC chromatograms and mass spectra to confirm purity and identity.
Method summaries and full raw-data packages available upon request for detailed review.
